← Back to all trials
Recruiting
NCT06396897
Hospital @ Home Model of Care for Cirrhosis
Conditions: Decompensated Cirrhosis
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 30
Sponsor: Indiana University
Location: IU School of Medicine Indianapolis Indiana
Summary
The purpose of this study is to work with patients diagnosed with end-stage liver disease to understand their perspectives on the Health at Home (H@H) Program, including desired outcomes and expectations, perceived barriers, and drivers. H@H is an emerging model of home-based care, designed to extend traditional, inpatient hospital care which may address these needs. Through H@H, acute medical care services as well as ancillary care such as rehabilitation therapy can be delivered in the home. The study is divided into three phases: Phase 1 occurs while the participant is an inpatient. Phase 2 is when the actual H@H program takes place as part of the participant's clinical care. The study team will not be involved in the Phase 2 - H@H program as it will be conducted by the clinical staff. Phase 3, at which point the participant enters a rehabilitation phase to transition the patient to self-management, involves a research jam session with the participant and caregiver to assess the value of the program.
Eligibility Criteria
Inclusion Criteria:
* Enrolled into IUH's H@H program
* At least 18 years of age
* Chronic liver disease/cirrhosis based on characteristic clinical, laboratory, and imaging findings
* English speaking
* Able to provide consent
* Caregiver able to be present during the acute phase of care (first 48 hours post-hospital discharge)
* Able to perform activities of daily living independently
* Lives within IU Health Home service area
Exclusion Criteria:
* Unable to complete study questionnaires due to neurocognitive disease, legal blindness or hearing loss
* Transplant of organ other than liver
* Pregnant
* Incarcerated
* New hemodialysis
* Blood pressure \< 90/60, Pulse \> 120, O2 \> 6L or \>2L above baseline
* HIV+/CD4 count \< 200
* Receiving hospice services
* Concurrent enrollment in a related research study
Source: ClinicalTrials.gov (NCT06396897). StuddyBuddy aggregates publicly available trial information.